165 related articles for article (PubMed ID: 36326315)
41. Development of new extra-glandular manifestations or associated auto-immune diseases after establishing the diagnosis of primary Sjögren's syndrome : A long-term study of the Antonius Nieuwegein Sjögren (ANS) cohort.
Ter Borg EJ; Kelder JC
Rheumatol Int; 2017 Jul; 37(7):1153-1158. PubMed ID: 28424927
[TBL] [Abstract][Full Text] [Related]
42. Prognosis and outcome of non-Hodgkin lymphoma in primary Sjögren syndrome.
Voulgarelis M; Ziakas PD; Papageorgiou A; Baimpa E; Tzioufas AG; Moutsopoulos HM
Medicine (Baltimore); 2012 Jan; 91(1):1-9. PubMed ID: 22198497
[TBL] [Abstract][Full Text] [Related]
43. Survival analysis of patients with Sjögren's syndrome in Turkey: a tertiary hospital-based study.
Yazisiz V; Göçer M; Erbasan F; Uçar İ; Aslan B; Oygen Ş; Gökalp Gök E; Terzioğlu ME
Clin Rheumatol; 2020 Jan; 39(1):233-241. PubMed ID: 31555987
[TBL] [Abstract][Full Text] [Related]
44. Increased incidence of Sjogren's syndrome in systemic sclerosis: A nationwide population study.
Tseng CC; Yen JH; Tsai WC; Ou TT; Wu CC; Sung WY; Hsieh MC; Chang SJ
Autoimmunity; 2015; 48(7):438-44. PubMed ID: 25980318
[TBL] [Abstract][Full Text] [Related]
45. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
[TBL] [Abstract][Full Text] [Related]
46. Sjögren's syndrome in patients with newly diagnosed untreated non-Hodgkin's lymphoma.
Andonopoulos AP; Tiniakou M; Melachrinou M; Sfountouris H; Bounas A; Zervas C; Zoumbos NC
Rev Rhum Engl Ed; 1997 May; 64(5):287-92. PubMed ID: 9190001
[TBL] [Abstract][Full Text] [Related]
47. Extraglandular ocular involvement and morbidity and mortality in primary Sjögren's Syndrome.
Mathews PM; Robinson SA; Gire A; Baer AN; Akpek EK
PLoS One; 2020; 15(9):e0239769. PubMed ID: 32976549
[TBL] [Abstract][Full Text] [Related]
48. Risk for malignancies of infectious etiology among adult survivors of specific non-Hodgkin lymphoma subtypes.
Herr MM; Schonfeld SJ; Dores GM; Engels EA; Tucker MA; Curtis RE; Morton LM
Blood Adv; 2019 Jul; 3(13):1961-1969. PubMed ID: 31262739
[TBL] [Abstract][Full Text] [Related]
49. Serum, but Not Saliva, CXCL13 Levels Associate With Infiltrating CXCL13+ Cells in the Minor Salivary Gland Lesions and Other Histologic Parameters in Patients With Sjögren's Syndrome.
Chatzis L; Goules AV; Stergiou IE; Voulgarelis M; Tzioufas AG; Kapsogeorgou EK
Front Immunol; 2021; 12():705079. PubMed ID: 34484201
[TBL] [Abstract][Full Text] [Related]
50. Predicting the risk for lymphoma development in Sjogren syndrome: An easy tool for clinical use.
Fragkioudaki S; Mavragani CP; Moutsopoulos HM
Medicine (Baltimore); 2016 Jun; 95(25):e3766. PubMed ID: 27336863
[TBL] [Abstract][Full Text] [Related]
51. Risk factors for progression and prognosis of primary Sjögren's syndrome-associated interstitial lung disease in a Chinese population.
Xu Y; Zhou J; Dong X; Guo X; Lu Y; Zheng Y
Int J Rheum Dis; 2020 Dec; 23(12):1734-1740. PubMed ID: 33226736
[TBL] [Abstract][Full Text] [Related]
52. [The relationship between Sjogren's syndrome, systemic sclerosis and lymphoproliferative diseases].
Vasil'ev VI; Chal'tsev BD; Gorodetskii VR; Pal'shina SG; Shornikova NS; Anan'eva LP; Gaiduk IV; Kokosadze NV; Probatova NA; Pavlovskaia AI; Rodionova EB; Safonova TN; Balabina AA
Ter Arkh; 2020 Dec; 92(12):126-136. PubMed ID: 33720584
[TBL] [Abstract][Full Text] [Related]
53. A clinical prediction rule for lymphoma development in primary Sjögren's syndrome.
Baldini C; Pepe P; Luciano N; Ferro F; Talarico R; Grossi S; Tavoni A; Bombardieri S
J Rheumatol; 2012 Apr; 39(4):804-8. PubMed ID: 22337248
[TBL] [Abstract][Full Text] [Related]
54. Risk of primary Sjogren's Syndrome following human papillomavirus infections: a nationwide population-based cohort study.
Chen HH; Ma KS; Dong C; Chang WJ; Gao KR; Perng WT; Huang JY; Wei JC
Front Immunol; 2022; 13():967040. PubMed ID: 36052092
[TBL] [Abstract][Full Text] [Related]
55. Non-Hodgkin's lymphoma associated with primary Sjögren's syndrome.
Pariente D; Anaya JM; Combe B; Jorgensen C; Emberger JM; Rossi JF; Sany J
Eur J Med; 1992 Oct; 1(6):337-42. PubMed ID: 1341461
[TBL] [Abstract][Full Text] [Related]
56. Clinical and imaging findings of lymphoma in patients with Sjögren syndrome.
Tonami H; Matoba M; Kuginuki Y; Yokota H; Higashi K; Yamamoto I; Sugai S
J Comput Assist Tomogr; 2003; 27(4):517-24. PubMed ID: 12886135
[TBL] [Abstract][Full Text] [Related]
57. Risk of Overall and Site-specific Cancers in Behçet Disease: A Nationwide Population-based Study in Taiwan.
Wang LH; Wang WM; Hsu SM; Lin SH; Shieh CC
J Rheumatol; 2015 May; 42(5):879-84. PubMed ID: 25834207
[TBL] [Abstract][Full Text] [Related]
58. Hematologic malignancies in patients with cryoglobulinemia: association with autoimmune and chronic viral diseases.
Trejo O; Ramos-Casals M; López-Guillermo A; García-Carrasco M; Yagüe J; Cervera R; Font J; Ingelmo M
Semin Arthritis Rheum; 2003 Aug; 33(1):19-28. PubMed ID: 12920693
[TBL] [Abstract][Full Text] [Related]
59. Subclinical atherosclerosis in primary Sjögren's syndrome: comparable risk with diabetes mellitus.
Zhang Y; Luo Q; Lu K; You M; Wang H
Clin Rheumatol; 2023 Jun; 42(6):1607-1614. PubMed ID: 36813944
[TBL] [Abstract][Full Text] [Related]
60. Lung involvement in patients with primary Sjögren's syndrome: what are the predictors?
Yazisiz V; Arslan G; Ozbudak IH; Turker S; Erbasan F; Avci AB; Ozbudak O; Terzioglu E
Rheumatol Int; 2010 Aug; 30(10):1317-24. PubMed ID: 19844720
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]